Sorafenib Completed Phase 2 Trials for Fallopian Tube Cancer / Primary Peritoneal Cancer / Neoplasms, Ovarian Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00791778Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer
NCT00436215Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer